Skip to main content

Dupixent (Dupilumab) & Signal Identification

Basic Details
Status
Ongoing
Last Updated
Wednesday, July 31, 2024
Original Posting Date
Health Outcome(s)
signal identification
Purpose
Signal Identification
Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR
No
Analytic Code Link(s) (1)
Outcome Monitoring Following Dupilumab Use: A Signal Identification Analysis
Result(s) (2)
Outcome Monitoring Following Dupilumab Use: A Signal Identification Analysis Utilization of Dupilumab: A Descriptive Analysis
Related Publication(s) and/or Presentation(s) (1)
Presentation: Tree-Based Mining of Real-World Data for Potential Safety Signals Associated with the Use of Dupilumab in the United States (2017-2023)